CIK 0001446159 · Non-accelerated filer<br>Smaller reporting company
AXE COMPUTE INC.
Sign in to watch- Ticker
- AGPU
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 331007393
- Phone
- 305-563-3850
- Business address
- 801 BRICKELL AVENUE, SUITE 510, MIAMI, FL, 33131
- Former names
- Predictive Oncology Inc., Precision Therapeutics Inc., Skyline Medical Inc., BioDrain Medical, Inc.
- Open-market buys, last 90 days
- $98,325
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$98,325. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-04 | MYERS ROBERT L Chief Financial Officer | Returned to the company · Stock Options (Right to buy) | −42 | 0 | ||
| 2020-09-04 | MYERS ROBERT L Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +42 | 42 | ||
| 2020-09-04 | MYERS ROBERT L Chief Financial Officer | Returned to the company · Stock Options (Right to buy) | −14 | 0 | ||
| 2020-09-04 | MYERS ROBERT L Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +14 | 14 | ||
| 2020-09-04 | MYERS ROBERT L Chief Financial Officer | Returned to the company · Stock Options (Right to buy) | −357 | 0 | ||
| 2020-09-04 | MYERS ROBERT L Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +357 | 357 | ||
| 2020-09-04 | MYERS ROBERT L Chief Financial Officer | Returned to the company · Stock Options (Right to buy) | −30,411 | 0 | ||
| 2020-09-04 | MYERS ROBERT L Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +30,411 | 30,411 | ||
| 2020-09-04 | MYERS ROBERT L Chief Financial Officer | Returned to the company · Stock Options (Right to buy) | −16,600 | 0 | ||
| 2020-09-04 | MYERS ROBERT L Chief Financial Officer | Grant or award · Stock Options (right to buy) | +16,600 | 16,600 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Returned to the company · Stock Options (Right to buy) | −20,000 | 0 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +20,000 | 20,000 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Returned to the company · Stock Options (Right to buy) | −4,219 | 0 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +4,219 | 4,219 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Returned to the company · Stock Options (Right to buy) | −5,128 | 0 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +5,128 | 5,128 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Returned to the company · Stock Options (Right to buy) | −6,050 | 0 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +6,050 | 6,050 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Returned to the company · Stock Options (right to buy) | −52 | 0 | ||
| 2020-09-04 | Schwartz Carl I. Chief Executive Officer | Grant or award · Stock Options (Right to buy) | +52 | 52 |
Page 9 of 20 · 384 trades